Cryo-Cell International, Inc.
CCEL
$4.97
$0.04570.93%
AMEX
05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
---|---|---|---|---|---|
Net Income | 98.16% | 101.32% | 104.22% | -456.17% | -505.57% |
Total Depreciation and Amortization | 14.97% | -15.60% | -40.27% | -37.53% | -33.55% |
Total Amortization of Deferred Charges | -1.87% | -1.86% | -1.85% | -1.84% | 26.63% |
Total Other Non-Cash Items | -87.42% | -89.70% | -91.91% | 3,317.39% | 5,057.96% |
Change in Net Operating Assets | -12.82% | 9.06% | -38.21% | 16.63% | -4.27% |
Cash from Operations | -6.68% | 5.82% | -32.61% | -10.08% | -23.40% |
Capital Expenditure | 95.59% | 70.99% | 64.85% | 19.39% | 44.70% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -169.87% | -675.99% | -89.40% | -60.29% | -37.08% |
Cash from Investing | 57.80% | 33.78% | 40.12% | -35.20% | 29.98% |
Total Debt Issued | 112.53% | 272.11% | 449.47% | -62.89% | -75.05% |
Total Debt Repaid | -252.87% | -146.45% | -41.87% | 36.46% | 70.86% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | 92.58% | -72.59% | -78.19% | -53.67% | -19.32% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -100.00% | 437.78% | 437.78% | 102.95% | 102.87% |
Cash from Financing | -372.80% | -231.47% | 52.76% | 69.79% | -33.22% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 49.34% | 97.87% | 111.93% | 83.48% | 61.04% |